Haemonetics Corporation (HAE)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
As of 10:11AM EDT. Market open.
| Previous close | 95.38 |
| Open | 95.47 |
| Bid | 95.57 x 800 |
| Ask | 96.09 x 1000 |
| Day's range | 95.53 - 96.32 |
| 52-week range | 70.74 - 96.32 |
| Volume | |
| Avg. volume | 480,881 |
| Market cap | 4.862B |
| Beta (5Y monthly) | 0.36 |
| PE ratio (TTM) | 38.92 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Exploring Analyst Estimates for Haemonetics (HAE) Q4 Earnings, Beyond Revenue and EPS
Evaluate the expected performance of Haemonetics (HAE) for the quarter ended March 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
- Zacks
Haemonetics (HAE) Banks on Plasma Arm Growth Amid Rising Costs
Haemonetics' (HAE) hospital portfolio is evolving and helping to create new opportunities for growth and diversification.
- Simply Wall St.
Is Haemonetics Corporation's (NYSE:HAE) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?
Haemonetics' (NYSE:HAE) stock is up by a considerable 12% over the past month. Given the company's impressive...
© 2024 Yahoo. All rights reserved.